Definitions of remission according to clinical, serological and therapeutic status allowed
Disease activity | Treatment | ||||
SLEDAI-2K | PGA | PDN | Antimalarials, biologics, immunosuppressants* | ||
Clinical | Serological | ||||
PDN ≤5 mg/day | Regardless | Regardless | Regardless | ≤5 mg/day | Regardless |
PGA <0.5 | Regardless | Regardless | <0.5 | Regardless | Regardless |
cSLEDAI=0 | 0 | Regardless | Regardless | Regardless | Regardless |
PDN ≤5 mg/day plus PGA <0.5 | Regardless | Regardless | <0.5 | ≤5 mg/day | Regardless |
cSLEDAI=0 plus PGA <0.5 | 0 | Regardless | <0.5 | Regardless | Regardless |
cSLEDAI=0 plus PDN ≤5 mg/day | 0 | Regardless | Regardless | ≤5 mg/day | Regardless |
cSLEDAI=0 plus PDN ≤5 mg/day plus PGA <0.5 | 0 | Regardless | <0.5 | ≤5 mg/day | Regardless |
*Stable well-tolerated doses.
cSLEDAI, clinical systemic lupus erythematosus Disease Activity Index 2000; PDN, prednisone equivalent; PGA, physician global assessment.